D57-12505-10007
2 vaccinations
6 coded responses
22 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 787 / TX
- Registered
- 2021-03-11
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-11
Registered in v-safe
-
2021-03-11
Dose 1 — Pfizer-BioNTech
-
2021-03-11
Survey response — day 0, dose 1MedDRA: Hyperhidrosis — Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessFree text: Perfuse sweatingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-12
Survey response — days 1–6 daily, dose 1MedDRA: Hyperhidrosis — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Fatigue or tiredness, NauseaFree text: PerspirationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2021-03-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-03-15
-
2021-03-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-03-17
- 2021-03-18
- 2021-03-25
-
2021-04-01
Dose 2 — Pfizer-BioNTech
-
2021-04-01
Survey response — day 0, dose 2MedDRA: Dizziness, Medical observation — Feeling: Poor · Site: Pain · Headache, Nausea, Vomiting, Diarrhea · Get care from a doctor or other healthcare professionalFree text: Systemic reaction (other): Dizziness · Healthcare visit (other): Care at vaccination location during observation waiting period.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-01
Report sent to call center — day 0, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-02
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-04-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-08
Health check-in — day 7, dose 2Feeling: Good · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-15
- 2021-04-23
-
2021-04-29
Survey response — day 28, dose 2MedDRA: Dyspnoea, Hyperhidrosis — Feeling: GoodFree text: Shortness of breathe and excessive perspirationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-11
Survey response — day 35, dose 2MedDRA: Arthralgia, Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: FatigueBody and joint painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-13
- 2021-06-08
- 2021-07-03
-
2022-04-02
Survey response — 12 months, dose 2MedDRA: Chest pain, Cough, Fatigue, Hyperhidrosis, Menstruation irregular, Postmenopausal haemorrhage — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Uncontrollable coughing some episodes end with burning chest with fatigue & perspiration. Menstrual cycle for 7 1/2 months (constant - no pause). Menopause in 2017 Increased periods of perspiration even when sitting without any activity.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-11 | Pfizer-BioNTech | |
| 2 | 2021-04-01 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): Perfuse sweating
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Perspiration
Release 6 — day 0, dose 2
Systemic reaction (other): Dizziness
Healthcare visit (other): Care at vaccination location during observation waiting period.
Release 8 — day 28, dose 2
Symptoms: Shortness of breathe and excessive perspiration
Release 8 — day 35, dose 2
Symptoms: FatigueBody and joint pain
Release 11 — 12 months, dose 2
Symptoms: Uncontrollable coughing some episodes end with burning chest with fatigue & perspiration. Menstrual cycle for 7 1/2 months (constant - no pause). Menopause in 2017 Increased periods of perspiration even when sitting without any activity.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical observation | ✓ | ✓ | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Hyperhidrosis | ✓ | ✓ | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Postmenopausal haemorrhage | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release